Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Inhaled Milrinone in Cardiac Surgery
NCT01725776Phase 2Completed
- Sponsor
- Montréal Heart Institute
- Start
- Dec 2006
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of milrinone in pulmonary hypertension (PH), sponsored by Montréal Heart Institute. Primary endpoint: Elimination rate of milrinone administered by inhalation at 24 hours. Started Dec 2006; status: completed.
02
Drugs
milrinone
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01725776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01725776.